Peter Campochiaro

Peter Campochiaro is a Professor of Ophthalmology at the Johns Hopkins School of Medicine, Department of Ophthalmology, where he conducts cutting-edge research on retinal diseases. He is affiliated with the Neuroscience Training Program and the Visual Neuroscience Training Program, reflecting his interdisciplinary approach.

His research focuses on the neurobiology of retinal degeneration, particularly retinitis pigmentosa (RP) and age-related macular degeneration (AMD). He investigates the role of oxidative stress in secondary cone death in RP and the transition to neovascular AMD, exploring therapeutic strategies such as antioxidant supplementation and gene therapy to enhance endogenous defense systems.

His recent publications demonstrate a strong trend in developing sustained delivery systems for anti-VEGF agents, gene therapy vectors (AAV), and nonviral nanoparticles for suprachoroidal delivery. His work spans basic science, translational models, and clinical trials, especially in diabetic macular edema and neovascular AMD.

• Professor of Ophthalmology, Johns Hopkins University
• Research focus: Oxidative stress, retinal degeneration, gene therapy
• Active in clinical trials for sustained ocular drug delivery

Scientific Awards:

• No awards explicitly mentioned in the provided text.

Advising and Grants: Dr. Campochiaro mentors numerous graduate students and postdoctoral researchers, many of whom appear as co-authors on his publications. His research is supported by extensive grant funding, evident from multi-center clinical trials and advanced therapeutic development projects, particularly in ocular gene therapy and drug delivery systems.

Labs and Teams: He leads a research team focused on molecular aspects of retinal repair and regeneration, collaborating with experts in biomaterials, nanotechnology, and computational modeling to innovate ocular therapeutics.